A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans

D. Voora; D. C. Koboldt; C. R. King; P. A. Lenzini; C. S. Eby; R. Porche-Sorbet; E. Deych; M. Crankshaw; P. E. Milligan; H. L. McLeod; S. R. Patel; L. H. Cavallari; P. M. Ridker; G. R. Grice; R. D. Miller; B. F. Gage

doi:10.1038/clpt.2009.291

A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans

D. Voora, D. C. Koboldt, C. R. King, P. A. Lenzini, C. S. Eby, R. Porche-Sorbet, E. Deych, M. Crankshaw, P. E. Milligan, H. L. McLeod, S. R. Patel, L. H. Cavallari, P. M. Ridker, G. R. Grice, R. D. Miller, B. F. Gage

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	445-451
Number of pages	7
Journal	Clinical Pharmacology and Therapeutics
Volume	87
Issue number	4
DOIs	https://doi.org/10.1038/clpt.2009.291
State	Published - Apr 2010
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1038/clpt.2009.291

Cite this

Voora, D., Koboldt, D. C., King, C. R., Lenzini, P. A., Eby, C. S., Porche-Sorbet, R., Deych, E., Crankshaw, M., Milligan, P. E., McLeod, H. L., Patel, S. R., Cavallari, L. H., Ridker, P. M., Grice, G. R., Miller, R. D., & Gage, B. F. (2010). A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. Clinical Pharmacology and Therapeutics, 87(4), 445-451. https://doi.org/10.1038/clpt.2009.291

Voora, D, Koboldt, DC, King, CR, Lenzini, PA, Eby, CS, Porche-Sorbet, R, Deych, E, Crankshaw, M, Milligan, PE, McLeod, HL, Patel, SR, Cavallari, LH, Ridker, PM, Grice, GR, Miller, RD & Gage, BF 2010, 'A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans', Clinical Pharmacology and Therapeutics, vol. 87, no. 4, pp. 445-451. https://doi.org/10.1038/clpt.2009.291

@article{da123bf463014d19a56d48c81d4b856b,

title = "A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans",

author = "D. Voora and Koboldt, \{D. C.\} and King, \{C. R.\} and Lenzini, \{P. A.\} and Eby, \{C. S.\} and R. Porche-Sorbet and E. Deych and M. Crankshaw and Milligan, \{P. E.\} and McLeod, \{H. L.\} and Patel, \{S. R.\} and Cavallari, \{L. H.\} and Ridker, \{P. M.\} and Grice, \{G. R.\} and Miller, \{R. D.\} and Gage, \{B. F.\}",

year = "2010",

month = apr,

doi = "10.1038/clpt.2009.291",

language = "English",

volume = "87",

pages = "445--451",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

number = "4",

}

TY - JOUR

T1 - A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans

AU - Voora, D.

AU - Koboldt, D. C.

AU - King, C. R.

AU - Lenzini, P. A.

AU - Eby, C. S.

AU - Porche-Sorbet, R.

AU - Deych, E.

AU - Crankshaw, M.

AU - Milligan, P. E.

AU - McLeod, H. L.

AU - Patel, S. R.

AU - Cavallari, L. H.

AU - Ridker, P. M.

AU - Grice, G. R.

AU - Miller, R. D.

AU - Gage, B. F.

PY - 2010/4

Y1 - 2010/4

UR - https://www.scopus.com/pages/publications/77949874684

UR - https://www.scopus.com/inward/citedby.url?scp=77949874684&partnerID=8YFLogxK

U2 - 10.1038/clpt.2009.291

DO - 10.1038/clpt.2009.291

M3 - Article

C2 - 20200517

AN - SCOPUS:77949874684

SN - 0009-9236

VL - 87

SP - 445

EP - 451

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 4

ER -

A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this